CYTARABINE — all Canadian products
19 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is CYTARABINE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02126656 | CYTARABINE INJECTION | PFIZER CANADA ULC | Solution | Intravenous; Intrathecal; Subcutaneous | CYTARABINE 100 MG | Marketed | |
| 02515296 | CYTARABINE INJECTION | STERIMAX INC | Solution | Intravenous; Subcutaneous; Intrathecal | CYTARABINE 100 MG | Marketed | |
| 02403811 | CYTOSAR | PHARMASCIENCE INC | Solution | Intrathecal; Intravenous; Subcutaneous | CYTARABINE 20 MG | Approved | |
| 02403838 | CYTOSAR | PHARMASCIENCE INC | Solution | Intravenous; Subcutaneous; Intrathecal | CYTARABINE 100 MG | Approved | |
| 02406772 | PMS-CYTARABINE | PHARMASCIENCE INC | Solution | Intrathecal; Subcutaneous; Intravenous | CYTARABINE 100 MG | Marketed | |
| 02404397 | AJ-CYTARABINE | AGILA JAMP CANADA INC | Solution | Subcutaneous; Intravenous; Intrathecal | CYTARABINE 100 MG | Cancelled Pre Market | |
| 02167883 | CYTARABINE - PWS 1GN/VIAL | NOVOPHARM LIMITED | Powder For Solution | Intravenous; Intrathecal; Subcutaneous | CYTARABINE 1 G | Cancelled Post Market | |
| 02167891 | CYTARABINE - PWS 2GM/VIAL | NOVOPHARM LIMITED | Powder For Solution | Intrathecal; Intravenous; Subcutaneous | CYTARABINE 2 G | Cancelled Post Market | |
| 02167875 | CYTARABINE - PWS 500MG/VIAL | NOVOPHARM LIMITED | Powder For Solution | Subcutaneous; Intravenous; Intrathecal | CYTARABINE 500 MG | Cancelled Post Market | |
| 00885797 | CYTARABINE INJ 100MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | Intravenous; Subcutaneous | CYTARABINE 100 MG | Cancelled Post Market | |
| 02394901 | CYTARABINE INJECTION BP | SANDOZ CANADA INCORPORATED | Solution | Intrathecal; Subcutaneous; Intravenous | CYTARABINE 100 MG | Cancelled Pre Market | |
| 02402203 | CYTARABINE INJECTION, MYLAN STD. | MYLAN PHARMACEUTICALS ULC | Solution | Intrathecal; Intravenous; Subcutaneous | CYTARABINE 100 MG | Cancelled Pre Market | |
| 02167867 | CYTARABINE-PWS 100MG/VIAL | NOVOPHARM LIMITED | Powder For Solution | Subcutaneous; Intravenous; Intrathecal | CYTARABINE 100 MG | Cancelled Post Market | |
| 00194727 | CYTOSAR | PHARMASCIENCE INC | Powder For Solution | Subcutaneous; Intravenous; Intrathecal | CYTARABINE 500 MG | Cancelled Post Market | |
| 00646318 | CYTOSAR | PHARMASCIENCE INC | Powder For Solution | Intravenous; Subcutaneous; Intrathecal | CYTARABINE 2 G | Cancelled Post Market | |
| 00646296 | CYTOSAR | PHARMASCIENCE INC | Powder For Solution | Intravenous; Subcutaneous; Intrathecal | CYTARABINE 1 G | Cancelled Post Market | |
| 00386715 | CYTOSAR | PHARMASCIENCE INC | Powder For Solution | Intrathecal; Intravenous; Subcutaneous | CYTARABINE 100 MG | Cancelled Post Market | |
| 02241150 | DEPOCYT | SKYEPHARMA INC. | Suspension | Intrathecal | CYTARABINE 10 MG | Cancelled Post Market | |
| 02406764 | PMS-CYTARABINE | PHARMASCIENCE INC | Solution | Intrathecal; Intravenous; Subcutaneous | CYTARABINE 20 MG | Dormant |
Browse other molecules: